Indivior Pharmaceuticals (INDV) Non Operating Interest Expenses (2024 - 2026)
Indivior Pharmaceuticals' Non Operating Interest Expenses was $2 million in Q2 2026, down 86.7% from $15 million a year earlier and down 71.4% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Non Operating Interest Expenses (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Indivior Pharmaceuticals' Non Operating Interest Expenses was $27 million through Jun 30, 2026, down 47.1% year-over-year; for FY2025, it was $45 million, up 9.8% from FY2024.
- Non Operating Interest Expenses has now increased for three consecutive years, with a four-year compound annual growth rate of 13.6% (FY2021 to FY2025).
- In earlier years, Non Operating Interest Expenses was $41 million in FY2024 (+17.1%), $35 million in FY2023 (+29.6%), $27 million in FY2022 (unchanged) and $27 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Non Operating Interest Expenses in data going back to Q1 2024.
- Compared with a year earlier, Non Operating Interest Expenses has declined for three straight quarters, with an average decline of 12.2% over the last six quarters.
- Per Business Quant data, INDV's Non Operating Interest Expenses in the three quarters before Q2 2026 was $7 million (Q1 2026), $6 million (Q4 2025) and $12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.23 Bn | 3.19 Bn | 294.00 Mn | 2.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
API Access
Indivior Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();